Gerber DA et al. |
Immunosuppressive agents: recent developments in molecular action and clinical application. |
1998 |
Transplant. Proc. |
pmid:9636637
|
Goulet O et al. |
Small bowel transplantation alone or with the liver in children: changes by using FK506. |
1998 |
Transplant. Proc. |
pmid:9636636
|
Stratta RJ |
Late acute rejection episodes after vascularized pancreas transplantation. |
1998 |
Transplant. Proc. |
pmid:9636633
|
Gruessner RW |
Antibody induction therapy in pancreas transplantation. |
1998 |
Transplant. Proc. |
pmid:9636632
|
Burke GW et al. |
Use of tacrolimus and mycophenolate mofetil for pancreas-kidney transplantation with or without OKT3 induction. |
1998 |
Transplant. Proc. |
pmid:9636627
|
Peddi VR et al. |
Long-term kidney and pancreas function with tacrolimus immunosuppression following simultaneous kidney and pancreas transplantation. |
1998 |
Transplant. Proc. |
pmid:9636626
|
Bruce DS et al. |
Tacrolimus/mycophenolate provides superior immunosuppression relative to neoral/mycophenolate in synchronous pancreas-kidney transplantation. |
1998 |
Transplant. Proc. |
pmid:9636625
|
Ciancio G et al. |
Use of intravenous tacrolimus to reverse vascular rejection in kidney and simultaneous kidney-pancreas transplantation. |
1998 |
Transplant. Proc. |
pmid:9636624
|
Schulz T et al. |
Tacrolimus/mycophenolate mofetil/steroid-based immunosuppression after pancreas-kidney transplantation with single shot antithymocyte globulin. |
1998 |
Transplant. Proc. |
pmid:9636623
|
Walker S et al. |
Clinical use and bioavailability of tacrolimus in heart-lung and double lung transplant recipients with cystic fibrosis. |
1998 |
Transplant. Proc. |
pmid:9636618
|
Wiebe K et al. |
FK506 rescue therapy in lung transplantation. |
1998 |
Transplant. Proc. |
pmid:9636613
|
Lipson DA et al. |
Conversion to tacrolimus (FK506) from cyclosporine after orthotopic lung transplantation. |
1998 |
Transplant. Proc. |
pmid:9636612
|
McAlister VC et al. |
Cost of liver transplantation using tacrolimus. |
1998 |
Transplant. Proc. |
pmid:9636611
|
Mueller AR et al. |
Influence of immunosuppression on patient outcome after liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636608
|
Maggard M et al. |
Incidence of acute rejection in African-American liver transplant recipients. |
1998 |
Transplant. Proc. |
pmid:9636607
|
Charco R et al. |
Hypercholesterolemia in long-term survivors of liver transplantation: a comparison between cyclosporine and FK 506. |
1998 |
Transplant. Proc. |
pmid:9636605
|
Nakamura M et al. |
Clinical and radiological features of two cases of tacrolimus-related posterior leukoencephalopathy in living related liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636600
|
Ghobrial RM et al. |
Retransplantation for recurrent hepatitis C following tacrolimus or cyclosporine immunosuppression. |
1998 |
Transplant. Proc. |
pmid:9636597
|
Platz KP et al. |
Indications for mycophenolate mofetil therapy in hepatitis C-patients undergoing liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636596
|
Lang M et al. |
Impact of immunosuppression in liver transplantation across a positive crossmatch. |
1998 |
Transplant. Proc. |
pmid:9636595
|
Mueller AR et al. |
Does initial graft function influence the outcome after liver transplantation? |
1998 |
Transplant. Proc. |
pmid:9636594
|
Cantarovich M et al. |
Optimal time points for the prediction of the area-under-the-curve in liver transplant patients receiving tacrolimus. |
1998 |
Transplant. Proc. |
pmid:9636592
|
Bekersky I et al. |
Bioequivalence of a new strength tacrolimus capsule under development. |
1998 |
Transplant. Proc. |
pmid:9636591
|
Liu WT et al. |
In vitro generation of tacrolimus metabolites and their detection in whole blood. |
1998 |
Transplant. Proc. |
pmid:9636590
|
Steinmueller T et al. |
Effect of CsA versus FK 506 on insulin sensitivity and insulin response using a modeling technique. |
1998 |
Transplant. Proc. |
pmid:9636589
|
Klupp J et al. |
Risk and benefit of antibody induction therapy in combination with tacrolimus immunosuppression after liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636585
|
Abe M et al. |
Successful prednisone withdrawal after living-related liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636584
|
Langrehr JM et al. |
Comparison of quadruple induction including ATG or IL-2R antibody with FK506-based therapy after liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636583
|
Bilbao I et al. |
Experience with neoral cyclosporine through the oral route in liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636580
|
Pratschke J et al. |
Treatment of cyclosporine-related adverse effects by conversion to tacrolimus after liver transplantation: long-term results. |
1998 |
Transplant. Proc. |
pmid:9636575
|
Rudich SM et al. |
Immunosuppression using tacrolimus, mycophenolate, and prednisone following orthotopic liver transplantation: a single-center experience. |
1998 |
Transplant. Proc. |
pmid:9636574
|
Ringe B et al. |
Tacrolimus and mycophenolate mofetil in clinical liver transplantation: experience with a steroid-sparing concept. |
1998 |
Transplant. Proc. |
pmid:9636573
|
Cai TH et al. |
Improved immunosuppression with combination tacrolimus (FK506) and mycophenolic acid in orthotopic liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636572
|
Taibi A et al. |
Rescue FK506 therapy for acute rejection and early chronic rejection after liver transplantation: report of 14 cases. |
1998 |
Transplant. Proc. |
pmid:9636571
|
Platz KP et al. |
FK506 for primary and rescue therapy following liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636570
|
Millis JM et al. |
Successful use of tacrolimus for initial rejection episodes after liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636569
|
Zervos XA et al. |
Comparison of tacrolimus with neoral as primary immunosuppression in hepatitis C patients after liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636568
|
Jain A et al. |
Liver transplantation under tacrolimus in infants, children, adults, and seniors: long-term results, survival, and adverse events in 1000 consecutive patients. |
1998 |
Transplant. Proc. |
pmid:9636567
|
Van Buren D et al. |
Renal function in primary liver transplant recipients receiving neoral (cyclosporine) versus prograf (tacrolimus). |
1998 |
Transplant. Proc. |
pmid:9636566
|
Wiesner RH |
Long-term comparison of tacrolimus versus cyclosporine in liver transplantation. The US FK Study Group. |
1998 |
Transplant. Proc. |
pmid:9636565
|
McDiarmid S et al. |
One hundred children treated with tacrolimus after primary orthotopic liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636564
|
Samuel D et al. |
Tacrolimus (FK506)-based dual versus triple therapy following liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636563
|
Rossi G et al. |
Three-year follow-up of low dose tacrolimus oral therapy after liver transplantation: a single-centre experience. |
1998 |
Transplant. Proc. |
pmid:9636562
|
Grewal HP et al. |
Corticosteroid cessation 1 week following renal transplantation using tacrolimus/mycophenolate mofetil based immunosuppression. |
1998 |
Transplant. Proc. |
pmid:9636558
|
Shapiro R et al. |
Outcome after steroid withdrawal in renal transplant patients receiving tacrolimus-based immunosuppression. |
1998 |
Transplant. Proc. |
pmid:9636557
|
Fitzsimmons WE et al. |
Demographic considerations in tacrolimus pharmacokinetics. |
1998 |
Transplant. Proc. |
pmid:9636552
|
Neylan JF |
Effect of race and immunosuppression in renal transplantation: three-year survival results from a US multicenter, randomized trial. FK506 Kidney Transplant Study Group. |
1998 |
Transplant. Proc. |
pmid:9636551
|
Kumar MS et al. |
ATGAM versus OKT3 induction therapy in cadaveric kidney transplantation: patient and graft survival, CD3 subset, infection, and cost analysis. |
1998 |
Transplant. Proc. |
pmid:9636549
|
Undre NA et al. |
Pharmacokinetics of FK 506 and mycophenolic acid after the administration of a FK 506-based regimen in combination with mycophenolate mofetil in kidney transplantation. |
1998 |
Transplant. Proc. |
pmid:9636527
|
Woodle ES et al. |
Meta-analysis of FK 506 and mycophenolate mofetil refractory rejection trials in renal transplantation. Refractory Rejection Meta-Analysis Study Group. |
1998 |
Transplant. Proc. |
pmid:9636526
|